We are live on
!
Find out more
SC
SMA Capital Portfolio holdings
AUM
$238M
This Fund
S&P 500
This Quarter
Est. Return
+14.62%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$238M
AUM Growth
+$6.45M
(+2.8%)
Cap. Flow
-$11.8M
Cap. Flow
% of AUM
-4.96%
Top 10 Holdings %
Top 10 Hldgs %
37.07%
Holding
184
New
89
Increased
22
Reduced
10
Closed
63
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$7.92M |
| 2 |
ITT
ITT
|
+$7.28M |
| 3 |
Packaging Corp of America
PKG
|
+$7.02M |
| 4 |
JB Hunt Transport Services
JBHT
|
+$6.42M |
| 5 |
Teledyne Technologies
TDY
|
+$6.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$10.3M |
| 2 |
Eaton
ETN
|
+$10.1M |
| 3 |
Caterpillar
CAT
|
+$9.48M |
| 4 |
Ferguson
FERG
|
+$8.32M |
| 5 |
Linde
LIN
|
+$7.49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 55.56% |
| 2 | Consumer Discretionary | 17.53% |
| 3 | Technology | 8.66% |
| 4 | Materials | 6.15% |
| 5 | Consumer Staples | 4.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Penumbra
PEN
$12.7B
| $30.9K | 0.01% |
98
+33
| +51% | +$10.7K |
|
77
Intuitive Surgical
ISRG
$131B
| $30.6K | 0.01% |
77
+32
| +71% | +$14K |
|
78
Axogen
AXGN
$2.77B
| $28K | 0.01% |
+606
| New | +$24.4K |
|
79
Alignment Healthcare
ALHC
$2.88B
| $27.7K | 0.01% |
1,165
+13
| +1% | +$250 |
|
80
Option Care Health
OPCH
$3.6B
| $27.7K | 0.01% |
1,320
+612
| +86% | +$14.2K |
|
81
Progyny
PGNY
$2.02B
| $27.6K | 0.01% |
+959
| New | +$21.4K |
|
82
Privia Health
PRVA
$2.69B
| $27.6K | 0.01% |
+1,074
| New | +$24.9K |
|
83
Glaukos
GKOS
$10.7B
| $27.5K | 0.01% |
+197
| New | +$24.9K |
|
84
Lifestance Health
LFST
$4.64B
| $27.5K | 0.01% |
+2,570
| New | +$19.9K |
|
85
Chemed
CHE
$7.17B
| $27.5K | 0.01% |
59
+6
| +11% | +$2.52K |
|
86
Clover Health Investments
CLOV
$2.26B
| $27.4K | 0.01% |
+5,221
| New | +$17.7K |
|
87
BridgeBio Pharma
BBIO
$15.5B
| $21K | 0.01% |
282
-71
| -20% | -$4.97K |
|
88
Revolution Medicines
RVMD
$46.2B
| $21K | 0.01% |
+112
| New | +$16.4K |
|
89
Gilead Sciences
GILD
$184B
| $20.8K | 0.01% |
+165
| New | +$21.7K |
|
90
Roivant Sciences
ROIV
$26.5B
| $20.8K | 0.01% |
+589
| New | +$17.4K |
|
91
Moderna
MRNA
$59.7B
| $20.8K | 0.01% |
297
-124
| -29% | -$6.42K |
|
92
Cytokinetics
CYTK
$11B
| $20.8K | 0.01% |
244
+145
| +146% | +$10.4K |
|
93
Ionis Pharmaceuticals
IONS
$10.5B
| $20.6K | 0.01% |
+260
| New | +$19.6K |
|
94
Axsome Therapeutics
AXSM
$10.9B
| $20.6K | 0.01% |
84
+48
| +133% | +$10.4K |
|
95
Neurocrine Biosciences
NBIX
$15.9B
| $20.6K | 0.01% |
+122
| New | +$18.1K |
|
96
Krystal Biotech
KRYS
$10.6B
| $20.4K | 0.01% |
+55
| New | +$16.4K |
|
97
Madrigal Pharmaceuticals
MDGL
$12.5B
| $20.4K | 0.01% |
+38
| New | +$19.5K |
|
98
Sotera Health
SHC
$5.58B
| $11.3K | ﹤0.01% |
639
+256
| +67% | +$4.04K |
|
99
Indivior Pharmaceuticals
INDV
$4.23B
| $11.3K | ﹤0.01% |
+276
| New | +$10K |
|
|
NUVL
100
DELISTED
Nuvalent
NUVL
| $11.1K | ﹤0.01% |
+90
| New | +$9.68K |
|
Similar funds
RMC
PFA
TCM
SAM
CWM
GRWP
CNBOF
NSB
SMA Capital's Q2 2026 Portfolio in Review
As of Q2 2026, SMA Capital held 184 positions worth $238M, up 2.8% from $232M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
SMA Capital withdrew a net $11.8M in Q2 2026, closing 63 positions and reducing 10 holdings. Its most notable exit was Boeing, an estimated $10.3M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 56% of assets, down from 79% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, SMA Capital opened a new position in CRH worth $7.7M.
- SMA Capital's largest Q2 2026 buy was CRH: 72,000 shares worth $7.7M.
- SMA Capital added most to Ametek in Q2 2026, an estimated $2.33M increase.
- SMA Capital's biggest Q2 2026 reduction was Applied Industrial Technologies, cutting an estimated $5.83M.
- SMA Capital fully exited Boeing in Q2 2026, selling an estimated $10.3M.
- SMA Capital's ten largest holdings make up 37% of its $238M portfolio in Q2 2026.
- SMA Capital opened 89 new positions and closed 63 in Q2 2026.
- SMA Capital's portfolio value rose 2.8% quarter-over-quarter to $238M.
Based on SMA Capital's 13F filing for Q2 2026, filed 14 Aug 2026.